Maria Cecilia Di Pentima

Maria Cecilia Di Pentima

Auto-generated profile, based on publicly available information

Maria Cecilia Di Pentima

Department of Pediatrics, Baystate Children's Hospital, Springfield, Massachusetts; Department of Pediatrics, UMass Chan Medical School - Baystate, Springfield, Massachusetts

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
PDF file
ZWZachary I. Willis
Zachary I. Willis
EDEileen M. Duggan
Eileen M. Duggan
JGJessica Gillon
Jessica Gillon
MBMartin Blakely
Martin Blakely
MPM. Cecilia Di Pentima
M. Cecilia Di Pentima
Background: Complicated appendicitis, characterized by perforation and/or peritonitis, is common in children, and late infectious complications are frequent. The best antibiotic treatment approach is unknown, resulting in substantial variation in care. We evaluated the effects of 2 successive interventions, an antimicrobial stewardship program (ASP) and a condition-specific clinical practice guideline (CPG), on antimicrobial utilization and patient outcomes in these patients. Methods: The ASP at our institution was begun in March 2012. The CPG, a standardized antibiotic treatment, was implemented in July 2013. We reviewed every case of complicated appendicitis managed with early appendectomy between January 2011 and October 2014. Patients were thus divided into 3 eras based on their exposure to the following: (1) neither intervention, (2) ASP only or (3) both ASP and CPG. We compared measures of antibiotic utilization and clinical outcomes among the 3 eras. Results: A total of 313 patients were included in the study: 91 exposed to neither intervention; 100 exposed to only the ASP; and 122 exposed to both interventions. With ASP implementation, there were declines in the use of unnecessarily broad or toxic antibiotic regimens. With CPG implementation, there was a decrease in total antibiotic utilization and discharges with intravenous antibiotics. Compliance with CPG-recommended antibiotics exceeded 90%. There was no significant change in overall adverse events; there was a decline in the incidence of surgical-site infections in patients exposed to both interventions. Conclusions: Complicated appendicitis is an important target for antimicrobial stewardship and quality improvement efforts. A condition-specific CPG can improve both antimicrobial utilization and clinical outcomes.

25 January 2021 in Journal of Paediatrics and Child Health
Verified
Journal Article
Open access
PDF file
CGChristina Gagliardo
Christina Gagliardo
EJErin Johnson
Erin Johnson
MPMaria Cecilia Di Pentima
Maria Cecilia Di Pentima
Click on the article title to read more.

24 March 2026 in Pediatric Neurology
Verified
Journal Article
Closed access
GNGeorgios Ntolkeras
Georgios Ntolkeras
RVRebekka Vogelgsang
Rebekka Vogelgsang
BRBeth Rosen
Beth Rosen
MLMartha Lopez
Martha Lopez
CDCecilia M. DiPentima
Cecilia M. DiPentima

4 December 2021 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
CGChristina Gagliardo
Christina Gagliardo
ENEberechi I Nwaobasi-Iwuh
Eberechi I Nwaobasi-Iwuh
NSNiva Shah
Niva Shah
APAparna Prasad
Aparna Prasad
NKNeeraja Kairam
Neeraja Kairam
MPM Cecilia Di Pentima
M Cecilia Di Pentima
Nearly 4 million children have tested positive for coronavirus disease 2019 (COVID-19) in the United States. Some studies suggest infants might be at increased risk for severe illness and hospitalization from COVID-19. Our objective was to describe the clinical and laboratory features of young infants admitted to a hospital system with COVID-19. An observational retrospective study was performed in infants ≤1 year of age admitted with COVID-19 from March 1, 2020 to May 30, 2021. Data was extracted into a REDCap database and analyzed using descriptive statistics. Sixteen infants < 1 year were hospitalized with COVID-19. Fever, poor feeding, and respiratory symptoms were the most common presenting symptoms (Table 1). Two required pediatric intensive care unit (ICU) care, three required oxygen support, and one was intubated. There were no deaths. Five infants with echocardiograms performed showed normal findings. Four infants received Remdesivir without side effects. Infants with COVID-19 can present with severe disease requiring ICU care and oxygen support. In our experience, a large proportion of infants developed hematologic abnormalities, but none had cardiac involvement. Preventive measures including vaccination will become critical to decrease transmission and severe disease in this young patient population. All Authors: No reported disclosures